Germany· DE-A57-9b3dda3a3a158198
Methocarbamol Aristo
A methocarbamol product containing methocarbamol, registered in Germany by Aristo Pharma Gmbh (Art 57). The same ATC class is registered in 12 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Methocarbamol is registered in 12 of 19 countries.
Countries holding a registration under ATC M03BA03 (methocarbamol), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 7 of them publish a price we can compare per daily dose
Methocarbamol · ATC M03BA03
12 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methocarbamol costs, country by country.
Normalised to the WHO defined daily dose (3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Methocarbamol · price per daily dose (3 g)
USD · FX 28 Sept 2026
- US United States$0.17 (acquisition cost)
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Methocarbamol
- Manufacturer
- Aristo Pharma Gmbh (Art 57)
- Country
- Germany (DE)
- ATC code
- M03BA03
- ATC class
- Methocarbamol
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
169 interactions on record for methocarbamol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methocarbamol · interactions on record
169 records
- 4 severe
- 53 moderate
- 112 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methocarbamol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesATMEKSIRosemont Pharmaceuticals LLC
- United KingdomMethocarbamol 1500mg tabletsConsilient Health Ltd
- CzechiaDOLIROBAXGOODWILL PHARMA Plc., Szeged
- SpainDOLIROBAX 500 MG COMPRIMIDOSFaes Farma S.A.
- SwitzerlandMetoflex 750 mg, comprimésLabatec Pharma SA
- FranceLUMIRELAX 10 %, crèmeLABORATOIRES JUVISE PHARMACEUTICALS
- NorwayMethocarbamol alAliud Pharma
- CanadaROBAXIN 750HALEON CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Methocarbamol Kwizda
- Czechia · Dolirobax
- Spain · Dolirobax, Molitrem
- France · Lumirelax, Methocarbamol Arrow
- United Kingdom (Northern Ireland) · Methocarbamol Activase Pharmaceuticals, Methocarbamol Amarox
- Hungary · Dolirobax Tabletta
- Luxembourg · Methocarbamol Micro Labs
- Malta · Rolaxifor
- Poland · Methocarbamol Espefa
- Portugal · Robaxisal, Zelaz
- Slovakia · Dolirobax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4a49a11b-e485-452b-a0cb-03b967c36352 GET /v1/drugs/4a49a11b-e485-452b-a0cb-03b967c36352?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Methocarbamol",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about methocarbamol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.